Home
Scan
Ask
Protocols
Profile
HomeIngredientsVitamin E
Reviewed by the Scan Dose Research Team and Clinical Advisory Board

Vitamin E

MODERATE EVIDENCEVitaminLast updated April 2026

SCAN DOSE SUMMARY

Vitamin E (alpha-tocopherol) is a fat-soluble antioxidant that protects cell membranes from oxidative damage. Our research shows a cautionary tale: early observational data suggested cardiovascular benefit, but large RCTs found high-dose vitamin E (≥400 IU/day) may INCREASE all-cause mortality. NAFLD and Alzheimer's disease remain the two conditions where vitamin E supplementation has positive evidence. For most healthy adults, supplementation is unnecessary and potentially harmful at high doses.

EVIDENCE GRADES

NAFLD/NASH (non-diabetic)Strong — PIVENS trial positive (PMID: 20427778)
B+
Alzheimer's (slowing progression)TEAM-AD trial positive at 2,000 IU/day (PMID: 24381967)
B-
Cardiovascular preventionLarge RCTs NEGATIVE; meta-analysis shows possible harm (PMID: 15537682)
D
Cancer preventionSELECT trial: no benefit; possible prostate cancer increase
D
All-cause mortality (high-dose)Meta-analysis: ≥400 IU/day associated with increased mortality (PMID: 15537682)
⚠️ HARM

OPTIMAL DOSAGE

  • RDA: 15mg (22.4 IU) alpha-tocopherol
  • NAFLD (clinical): 800 IU/day (physician-supervised)
  • Alzheimer's (clinical): 2,000 IU/day (physician-supervised)
  • Upper limit: 1,000mg/day (1,500 IU natural, 1,100 IU synthetic)
  • Do NOT supplement >400 IU/day without medical indication
  • Natural (d-alpha-tocopherol) is 2x more bioactive than synthetic (dl-alpha-tocopherol)
Scan a supplement containing Vitamin E

DRUG INTERACTIONS

Warfarin / anticoagulantsSevere

Vitamin E has anticoagulant properties at >400 IU; increased bleeding risk

AspirinModerate

Additive antiplatelet effects

Statins + niacinModerate

Vitamin E may reduce HDL-raising effect of niacin combination therapy

Chemotherapy / radiationModerate

Antioxidant may protect cancer cells from oxidative treatment

CyclosporineModerate

May alter cyclosporine metabolism

SAFETY PROFILE

Drug Interactions

⚠️ Mortality Concern

A 2005 meta-analysis of 135,967 participants found high-dose vitamin E (≥400 IU/day) was associated with increased all-cause mortality (RR 1.04, 95% CI 1.01-1.07) (PMID: 15537682). The effect was dose-dependent. This analysis changed clinical practice and led to recommendations against routine high-dose vitamin E supplementation.

Pregnancy & Lactation

  • RDA during pregnancy is 15mg. Supplemental doses within RDA are safe. High-dose supplementation (>400 IU) is not recommended.

WADA Status

Not Prohibited

HOW SCAN DOSE SCORES THIS

Products >400 IU per serving: automatic mortality risk flag
Natural form (d-alpha-tocopherol) scores higher than synthetic (dl-alpha-tocopherol)
Mixed tocopherols (gamma, delta, beta) score bonus — more representative of dietary vitamin E
Products containing only alpha-tocopherol at high doses: flag for gamma-tocopherol displacement
Warfarin users: automatic bleeding risk alert
Cancer patients on active treatment: flag antioxidant opposition concern
NAFLD indication at 800 IU: note this is a supervised medical use with positive trial data

CLINICAL REFERENCES

1.

Sanyal AJ et al. Pioglitazone, vitamin E, or placebo for NASH (PIVENS trial).

PMID: 20427778

2.

Dysken MW et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease (TEAM-AD trial).

PMID: 24381967

3.

Miller ER et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.

PMID: 15537682

4.

Lippman SM et al. Effect of selenium and vitamin E on risk of prostate cancer (SELECT trial).

PMID: 18997197

RELATED RESEARCH

Acerola Cherry
Amla
BiotinBiotin is a cofactor for five carboxylase enzymes critical to metabolism: pyruva
Amla
Scan Your Vitamin E SupplementBrowse all ingredients

Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated: April 2026

Not medical advice. Based on published clinical research and systematic reviews.

Safety

Vitamin E: Drug Interactions

Use with caution

Moderate interactions. Monitoring, timing separation, or dose adjustment may be required.

  • Warfarin and other anticoagulants

    High-dose vitamin E (over 400 IU) inhibits platelet aggregation.

    RiskIncreased bleeding risk.
    ActionLimit to under 400 IU per day if on anticoagulants. Monitor INR.

    Source: Clinical pharmacology

  • Aspirin and NSAIDs

    Additive antiplatelet effect.

    RiskIncreased bleeding.
    ActionUse caution at high doses.

    Source: Clinical consensus

  • Chemotherapy (alkylating agents)

    Vitamin E is an antioxidant that may protect cancer cells from oxidative damage.

    RiskPotential reduced chemo efficacy.
    ActionAvoid during active chemo. Discuss with your oncologist.

    Source: Theoretical, debated

  • Statins combined with niacin

    High-dose vitamin E may blunt the HDL-raising effect of the statin-niacin combo.

    RiskReduced cardiovascular benefit.
    ActionClinical significance unclear.

    Source: Limited evidence

Stop 2 weeks before surgery

High-dose bleeding risk.

Educational information only. This is not medical advice. These statements have not been evaluated by the FDA. Talk to your prescriber before starting, stopping, or combining any supplement with prescription medication.

Discover More

Explore
Browse All 538 IngredientsBrowse All 20 Conditions